Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
4.65 USD | +0.87% | +1.75% | +12.86% |
03:10pm | Oppenheimer Adjusts Achieve Life Sciences Price Target to $11 From $18, Maintains Outperform Rating | MT |
05-09 | Transcript : Achieve Life Sciences, Inc., Q1 2024 Earnings Call, May 09, 2024 |